1. Russian Federation Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
IMCB PJSC

IMCB PJSC

MMOEX:GEMA
90.70
RUB
-3.20
(-3.41%)
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
TTM
Revenue per Share
- -
16.68
19.12
17.76
16.25
17.81
17.06
- -
8.8
Basic EPS, GAAP
- -
10.46
11.17
8.88
8.22
9.14
6.58
- -
3.75
Free Cash Flow per Basic Share
- -
8.66
12.85
8.42
8.86
15.97
16.16
- -
- -
Dividend per Share
- -
9.41
11.89
6.21
5.7
10.06
9.45
- -
- -
Book Value per Share
2.83
4.2
3.48
13.14
14.06
13.5
9.34
29.53
39.51
Tangible Book Value per Share
2.81
3.87
3.18
10.88
11.88
11.66
3.28
23.87
33.56
Basic Weighted Avg Shares
- -
13
13
13
15
15
15
- -
15
Sales/Revenue/Turnover
- -
212
243
239
243
266
255
284
131
Operating Margin (%)
- -
61.95
58.04
55.19
54.64
52.06
50.39
52.72
31.38
Depreciation Expense
- -
5
6
5
10
8
1
1
- -
Net Income, GAAP
- -
133
142
119
123
137
98
126
56
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
62.71
58.43
49.98
50.6
51.34
38.55
44.36
42.56
Working Capital
-34
5
-9
16
3
425
-7
64
18
LT Debt
- -
- -
1
31
58
59
253
246
228
Total Equity
36
53
44
196
210
202
139
441
590
Return on Invested Capital (%)
- -
298.86
348.44
102.33
53.28
54.86
43.06
29.23
7.44
Return on Capital (%)
- -
293.33
285.47
90.46
52.09
53.53
35.22
29.1
11.58
Return on Common Equity (%)
- -
297.77
290.8
99.22
60.46
66.34
57.59
43.35
13.21

Capital Structure

RUB

•

in mil. unless spec.
Sep'22
Dec'22
Mar'23
ST Debt
- -
2
5
LT Borrowings
230
228
- -
LT Finance Leases
- -
20
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
15
1
15
Market Capitalization
- -
- -
- -

Working Capital

RUB

•

in mil. unless spec.
Sep'22
Dec'22
Mar'23
Total Current Assets
110
137
155
Cash, Cash Equivalents & STI
66
81
88
Accounts Receivable, Net
39
47
62
Inventories
6
5
5
Total Current Liabilities
163
152
137
Payables & Accruals
- -
- -
- -
ST Debt
- -
2
5
Deferred Revenue
- -
- -
- -

Growth Rates

RUB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
106.45%
216.24%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
-0.34%
28.13%
Sales/Revenue/Turnover
- -
3.34%
11.32%
Total Cash Common Dividend
- -
2.94%
-12.99%

Quarterly Revenue

RUB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
64
66
68
68
266
2022
66
- -
- -
62
255
2023
69
- -
- -
70
284

Quarterly Earnings Per Share

RUB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
2.49
- -
- -
- -
9.14
2022
2.3
- -
- -
- -
6.58
2023
2.3
- -
- -
- -
- -

Quarterly Dividends Per Share

RUB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
10.06
2022
- -
- -
- -
- -
9.45
2023
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Prikhodko Alexander Viktorovich
Full Time Employees
17
Sector
Health services
Industry
Medical/Nursing services
Address
Building 1 Moscow MC Russian Federation 119333
IPO Date
Jul 25, 2019
Website
gemabank.ru
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company, known as Gemabank, functions as a prominent licensed institution specializing in the private storage of cord blood stem cells and umbilical cord tissue across Russia and the Commonwealth of Independent States. The biotechnology enterprise, established in 2003 and headquartered in Moscow, Russia, facilitates bioinsurance services and actively engages in research for advanced gene therapy treatments. The company has demonstrated solid financial performance, reporting a 5.7% increase in net profit and a 20.3% rise in revenue for the first nine months of 2024. This entity operates as a subsidiary of Human Stem Cells Institute PJSC.